HBA panel: True healthcare reform requires a better connection to patients

HBA panel: True healthcare reform requires a better connection to patients

Four women hailing from all corners of the healthcare industry took the stage at the Healthcare Businesswomen’s Assn. conference this month for a free-ranging discussion moderated by WBUR reporter Martha Bebinger.

Each seemed frustrated with "band-aids" – the industry’s tendency to focus on using innovation to fix the U.S. healthcare system’s flaws. The real issue, they said, is the disconnect between healthcare executives and U.S. patients.

"We in healthcare haven’t figured out what is important to patients. Until we figure that out, all the technology in the world isn’t going to help us," said Dr. Karen Boudreau, CMO of Boston Medical Center HealthNet, striking a chord with the 170 women in the audience.

That’s not as easy as it sounds. Novel medical devices and drugs have taught Buket Grau, a senior director at Biogen Idec (NSDQ:BIIB) and former global commercial strategy director at Stryker (NYSE:SYK), that patients often behave in ways technologists and doctors don’t expect.

For example, she theorized, obesity-fighting devices like gastric stimulation might not work because on some level patients decide to ignore the device’s mechanically-induced message to stop eating. This mind-over-machine effect might explain the limited clinical effectiveness of gastric stimulation in the States.

"If you look at medtech, it used to be that we used to make innovation decisions based on investments," Grau said. "Now, for all stakeholders, putting patients in the center – this is becoming a priority in conversations."

Another example of the patient / healthcare provider disconnect is "smart" packaging – a souped-up pill bottle designed to boost compliance rates by reminding patients to take their pills and sending the data to their physician.

HBA panel: True healthcare reform requires a better connection to patients

(L-R) Boudreau, Fitzgerald, Grau, Bennett and Bebinger

The smart packaging innovation did not become a truly game-changing technology because its inventors didn’t address the root cause of poor compliance before designing a fix. Patients often choose not to take their medication (rather than forgetting), according to Wool Labs COO Michelle Bennett. Understanding why is the first step to boosting compliance, Bennett said.

Wool Labs is a consulting company that analyzes online patient conversations. Bennett said she sees a lot of patients taking the reins of their own health decisions and increasingly deferring to trusted peers rather than doctors. Healthcare reform needs to make room for patient advocates – non-MD experts to liaise between the patient and the healthcare provider, she said.

Anne Fitzgerald, network development vice president at Brigham & Women’s Hospital in Boston, echoed Bennett in emphasizing the need to tap into patients’ perspectives, which are often invisible to healthcare providers.

"Patients share things with each other that they don’t share with physicians," Fitzgerald said.

All the innovation in the world – from gastric stimulation to smart pill bottles – won’t improve health if patients still feel healthcare is happening at them, rather than for them, Bennett added.

The upshot, according to the panel, is that patients are less and less likely to trust their healthcare providers. Healthcare reform is forcing executives to seriously examine this misalignment.

RSS From Medical Design & Outsourcing

  • GlobTek presents its latest level VI AC/DC adapter and connverter
    T-43086-WWVV-X.X-Q Model is an addition to GlobTek’s Level VI compliant GT-43086 family and represents GlobTek’s 6 Watt wall plug-in series of AC/DC adapters (power supplies and chargers) with International Interchangeable blades. GlobTek’s changeable input blade system with individual field replaceable input plugs, including: North America and Japan NEMA 1-15P, Australian, UK BS 1363, European CEE […]
  • Sanmina’s familiarity with FDA gets skin treatment product to market fast
    The medical market for cosmetic devices is booming. However, quickly launching new products to meet demand is becoming more challenging because device manufactures face increased regulatory scrutiny. To help meet regulatory requirements, aesthetic and other medical-device OEMs are partnering with electronics manufacturing services (EMS) companies that also offer expertise with the FDA filings necessary to […]
  • Fluid connectors and quick disconnects for IVD equipment from CPC
    Colder Products Company (CPC) offers thousands of tubing connectors, quick disconnects and fittings for smart fluid handling in IVD and analytical equipment. Non-spill connectors speed testing throughput by eliminating drips, preventing air inclusion and increasing operator safety. Panel mount connectors can be added to existing equipment or bottle caps to provide secure, leak-free connections. Puncture […]
  • 310 Watt desktop medical power supply meets efficiency level VI requirements
    Power Partners releases a new 310 Watt medical grade desktop power supply from their PEAMD Series of AC and DC adapters. The 310 Watt unit is packed for ideal performance inside a compact case measuring 7.8 x 4 x 2 in. with a weight of only 3 lbs. The PEAMD310 Series is approved to the latest […]
  • Saelig introduces Multiple Instrument System MIS4 universal test system
    Saelig Company has introduced the ABI Electronics’ Multiple Instrument Station MIS4, an all-in-one testing tool that provides all commonly required test instruments in one compact programmable hardware module, mounted in a compact case or installed in a PC-drive bay. Controlled by ABI’s sophisticated SYSTEM 8 Ultimate PC software with a simple yet programmable operator interface, […]
  • AssurX announces document management software update for small to mid-size companies in FDA regulated industries
    AssurX, an enterprise quality management, risk and regulatory compliance solution provider, announces the release of the latest update to their AssurX document management software. The document management solution provides a cost-effective solution for small to medium sized companies faced with streamlined operations and is fully compliant for FDA regulated industries. Ideal solution for small to […]
  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]

Leave a Reply